SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-029790
Filing Date
2019-05-15
Accepted
2019-05-15 17:26:36
Documents
75
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a19-7753_110q.htm 10-Q 825352
2 EX-31.1 a19-7753_1ex31d1.htm EX-31.1 12505
3 EX-31.2 a19-7753_1ex31d2.htm EX-31.2 11991
4 EX-32.1 a19-7753_1ex32d1.htm EX-32.1 5370
5 EX-32.2 a19-7753_1ex32d2.htm EX-32.2 4913
  Complete submission text file 0001104659-19-029790.txt   6026327

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctrv-20190331.xml EX-101.INS 1327859
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctrv-20190331.xsd EX-101.SCH 55674
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctrv-20190331_cal.xml EX-101.CAL 44835
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctrv-20190331_def.xml EX-101.DEF 266146
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ctrv-20190331_lab.xml EX-101.LAB 522543
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctrv-20190331_pre.xml EX-101.PRE 411525
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36856 | Film No.: 19829776
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1